Kevin Koch - May 1, 2025 Form 4 Insider Report for Edgewise Therapeutics, Inc. (EWTX)

Role: President and CEO, Director
Signature: /s/John R. Moore Attorney-in-Fact for Kevin Koch
Stock symbol: EWTX
Transactions as of: May 1, 2025
Transactions value $: -$70,358
Form type: 4
Date filed: 5/7/2025, 09:10 PM
Previous filing: Mar 11, 2025
Next filing: Aug 14, 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
KOCH KEVIN	President and CEO, Director	C/O EDGEWISE THERAPEUTICS, INC., 1715 38TH STREET, BOULDER	/s/John R. Moore Attorney-in-Fact for Kevin Koch	2025-05-07	0001185829

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	EWTX	Common Stock	Options Exercise	$0	+10.4K	+71.95%	$0.00	24.9K	May 1, 2025	Direct
transaction	EWTX	Common Stock	Sale	-$70.4K	-4.28K	-17.18%	$16.45	20.6K	May 2, 2025	Direct	F1, F2
holding	EWTX	Common Stock						26.4K	May 1, 2025	Adrienne R. Koch Heritage Trust
holding	EWTX	Common Stock						260K	May 1, 2025	KTK Family Enterprise, LLC
holding	EWTX	Common Stock						26.4K	May 1, 2025	Matthew K. Koch Heritage Trust
holding	EWTX	Common Stock						26.4K	May 1, 2025	Nicole M. Soldow Heritage Trust
holding	EWTX	Common Stock						26.4K	May 1, 2025	See Footnotes

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	EWTX	Restricted Stock Units	Options Exercise	$0	-10.4K	-100%	$0.00	0	May 1, 2025	Common Stock	10.4K	$0.00	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents the number of shares sold to cover the statutory tax withholding obligations in connection with the vesting of Restricted Stock Units (RSUs). This sale satisfies the minimum statutory tax withholding obligations to be funded by a "sell-to-cover" transaction and does not represent a discretionary sale by the Reporting Person.
F2	The price reported in column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $16.07 to $16.84, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Content

Represents the number of shares sold to cover the statutory tax withholding obligations in connection with the vesting of Restricted Stock Units (RSUs). This sale satisfies the minimum statutory tax withholding obligations to be funded by a "sell-to-cover" transaction and does not represent a discretionary sale by the Reporting Person.

The price reported in column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $16.07 to $16.84, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.